Keywords: barr, portia, approved, launched, canada, pharmaceuticals, says
Barr's Portia approved and launched in Canada
Article | 03 September 2007
Barr Pharmaceuticals says that its subsidiary, Barr Laboratories, has received approval from the Therapeutic Products Directorate of Health Canada for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
